Citius Oncology (CTOR)

• Market cap: $139M
• 1 day: -4.57%
• 5 days: -4.02%
• 1 month: -11.64%
• 3 months: -18.93%
• 6 months: 89.77%
• Year to date: 40.34%
• 1 year: 62.14%
• 5 years: -83.45%
• 10 years: -83.45%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.